Alaunos Therapeutics

(NASDAQ) TCRT

Current Price$2.43

Market Cap$6.42M

Since IPO (2005)-99%

5 Year-99%

1 Year+3%

1 Month-9%

Alaunos Therapeutics Financials at a Glance

Market Cap

$6.42M

Revenue (TTM)

$5.00K

Net Income (TTM)

$4.18M

EPS (TTM)

$-2.25

P/E Ratio

-1.20

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$2.43

Volume

37,130.673

Open

$2.70

Price

$2.43

Volume

37,130.673

Open

$2.70

Previous Close

$2.70

Daily Range

$2.37 - $2.70

52-Week Range

$1.67 - $6.20

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$2.43

Volume

37,130.673

Open

$2.70

Previous Close

$2.70

Daily Range

$2.37 - $2.70

52-Week Range

$1.67 - $6.20

TCRT News

Medical professional holding dollar sign paperweight

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alaunos Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Holger Weis, CPA

Website

www.alaunos.com

Headquarters

Houston, TX 77054, US

TCRT Financials

Key Financial Metrics (TTM)

Gross Margin

-36%

Operating Margin

-845%

Net Income Margin

-835%

Return on Equity

-198%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-83.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.42M

Shares Outstanding

2.38M

Volume

37.13K

Avg. Volume

15.74K

Financials (TTM)

Gross Profit

$5.00K

Operating Income

$4.22M

EBITDA

$4.22M

Operating Cash Flow

$2.87M

Capital Expenditure

$98.00K

Free Cash Flow

$2.97M

Cash & ST Invst.

$1.39M

Total Debt

$0.00

Alaunos Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$3.00K

-25.0%

Gross Profit

$3.00K

-25.0%

Gross Margin

100.00%

N/A

Market Cap

$6.42M

N/A

Market Cap/Employee

$6.42M

N/A

Employees

N/A

Net Income

$893.00K

-20.4%

EBITDA

$900.00K

-21.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$1.39M

+26.9%

Accounts Receivable

$3.00K

-40.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.41%

N/A

Return on Invested Capital

-1.96%

N/A

Free Cash Flow

$553.00K

+6.6%

Operating Cash Flow

$552.00K

+6.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.36-6.24%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.67-3.04%

IBOImpact BioMedical Inc.

IBOImpact BioMedical Inc.$0.66+0.27%

ADXNAddex Therapeutics Ltd

ADXNAddex Therapeutics Ltd$6.54-0.83%

QNRXQuoin Pharmaceuticals, Ltd.

QNRXQuoin Pharmaceuticals, Ltd.$5.39-1.19%

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.65+1.47%

AIMAIM ImmunoTech Inc.

AIMAIM ImmunoTech Inc.$0.52+0.81%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$11.09+0.04%

POETPoet Technologies

POETPoet Technologies$7.89-0.01%

ERASErasca

ERASErasca$9.83-0.49%

TSLATesla

TSLATesla$377.32-0.00%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$53.96+0.03%

AALAmerican Airlines Group

AALAmerican Airlines Group$11.59-0.01%

FFord Motor Company

FFord Motor Company$12.35-0.01%

Questions About TCRT

What is the current price of Alaunos Therapeutics?

Alaunos Therapeutics is trading at $2.65 per share.

What is the 52-week range for Alaunos Therapeutics?

Over the past 52 weeks, Alaunos Therapeutics has traded between $1.67 and $6.20.

How much debt does Alaunos Therapeutics have?

As of the most recent reporting period, Alaunos Therapeutics reported total debt of N/A.

How much cash does Alaunos Therapeutics have on hand?

Alaunos Therapeutics reported $1.39M in cash and cash equivalents in its most recent financial results.

What is Alaunos Therapeutics’s dividend yield?

Alaunos Therapeutics does not currently have a dividend yield.

Alaunos Therapeutics

Alaunos Therapeutics Financials at a Glance

TCRT News

Why Alaunos Therapeutics Triumphed On Tuesday

Why Alaunos Therapeutics Stock Is Soaring Today

Why Alaunos Therapeutics Stock Sank Today

Why Alaunos Therapeutics Topped the Market on Tuesday

Why Alaunos Therapeutics Stock Is Up Yet Again Today

Why Alaunos Therapeutics Stock Is Tumbling Today

Why Alaunos Therapeutics' Shares Jumped 48.9% This Week

Why Alaunos Therapeutics Stock Was On Fire Today

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alaunos Therapeutics

TCRT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alaunos Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TCRT

What is the current price of Alaunos Therapeutics?

What is the 52-week range for Alaunos Therapeutics?

How much debt does Alaunos Therapeutics have?

How much cash does Alaunos Therapeutics have on hand?

What is Alaunos Therapeutics’s dividend yield?

Premium Investing Services